RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TANI M
Collezione ASL Biella

Items : 7

Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single-arm FIL-BRB trial. in British journal of haematology / Br J Haematol. 2025 Feb;206(2):556-564. doi: 10.1111/bjh.19920. Epub 2024 Nov 27.

2025
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara
ASL Biella

Freilone R; Varettoni M; Ferrero S; Tani M; Sartori R; Merli M; Pietrantuono G; Musuraca G; Tosi P; Mannina D; Ferrante M; Gaidano G; Caravita di Toritto T; Rossi FG; Califano C; Curreli L; Cavallo F; Conconi A; Boccomini C; Dessi D; Castiglione A; Monaco F; Drandi D; Villivà N; Benevolo G;

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.

2024
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara
ASL Biella

Bonomini L; Vitolo U; Cesaretti M; Esposito F; Pirosa MC; Pinotti G; Dore F; Pisani F; Zanni M; Ghiggi C; Liberati AM; Annibali O; Cabras MG; Celli M; Orsucci L; Tani M; Bruna R; Vanazzi A; Tucci A; Merli F; Balzarotti M; Gaidano G; Sassone M; Zucca E; Botto B; Stathis A; Ferreri AJM; Chiappella A; Conconi A; et alii...

Treatment of Relapsed/Refractory Waldenström Macroglobulinemia Patients: Final Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL) in Blood

2021
ASL Biella

Benevolo G; Ferrero S; Villivà N; Castiglione A; Monaco F; Boccomini C; Cabras MG; Califano C; Casula P; Cavallo F; Conconi A; Drandi D; Gaidano G; Gregorini AI; Felici S; Ferrante M; Mannina D; Molinari AL; Musto P; Musuraca G; Merli M; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice. in The oncologist / Oncologist. 2019 Sep;24(9):1246-1252. doi: 10.1634/theoncologist.2018-0603. Epub 2019 Apr 2.

2019
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino

Zinzani PL; Argnani L; Gaudio F; Castellino C; Zancanella M; Paolini R; Rigacci L; Fama A; Romano A; Monaco F; Devizzi L; Musuraca G; Patti C; Tecchio C; Marasca R; Goldaniga MC; Marino D; Balzarotti M; Cox MC; Conconi A; Tani M; Cascavilla N; Chiappella A; Visco C; Casadei B; Broccoli A;

The role of central nervous system prophylaxis and contralateral testis radiotherapy in primary testicular lymphoma: Long term analysis of the phase II IELSG10 study and preliminary results of the IELSG30 study of international extranodal lymphoma study group and fondazione Italiana linfomi in Haematologica

2019
ASL Biella

Chiappella A; Zucca E; Ferreri AJM; Ciccone G; Vanazzi A; Martelli M; Tucci A; Balzarotti M; Merli F; Cabras MG; Nassi L; Pavone V; Storti S; Tani M; Molinari AL; Conconi A; Gomez H; Lopez-Guillermo A; Sarris AH; Ricardi U; Gospodarowicz MK; Cavalli F; Vitolo U;

Clinical and molecular results of the phase II BRB (bendamustine, rituximab and bortezomib) trial of the fondazione italiana linfomi (FIL) for relapsed/refractory waldenström macroglobulinemia patients in Blood

2018
ASL Biella

Benevolo G; Ferrero S; Andriani A; Castiglione A; Baraldi A; Boccomini C; Cabras MG; Califano C; Cavallo F; Conconi A; Curreli L; Drandi D; Gaidano G; Felici S; Ferrante M; Mannina D; Merli M; Molinari AL; Musto P; Musuraca G; Rossi FG; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

IELSG-38: A phase II study of chlorambucil in combination with rituximab followed by maintenance therapy with subcutaneous rituximab in patients with extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT) in Blood

2017
ASL Biella

Stathis A; Gregorini A; Gressin R; Orsucci L; Perrot A; Tani M; Coiffier B; Musuraca G; Guieze R; Marino D; Gini G; Ferrari A; Gyan E; Morschhauser F; Palombi F; Cavallo F; Gouill SL; Tilly H; Salvi F; Conconi A; Cabras MG; Capochiani E; Califano C; Molinari AL; Pulsoni A; Ielmini N; Luminari S; Cavalli F; Zucca E; et alii...